Cabinet approval has been granted for Ireland to enter an EU agreement where Ireland will receive 4.9 million doses of the Pfizer-BioNTech vaccine in 2022 and 2023.
Ireland will also keep their option of securing 9.8 million doses over the same time period. This new EU agreement will allow for the vaccination of approximately 2.45 million people with two doses.
This comes as ministers were told that the immunity produced from the vaccine is unknown which means that boosters may be necessary.
Cabinet was also told that it is likely for vaccinations to be extended to those under the age of 16. It is understood that the doses, under the new agreement, will be subject to formulation updates which would allow the vaccine to be more portable, less perishable and enable it to be stored in standard refrigeration.